Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.

Chiappini E, Galli L, Tovo PA, Gabiano C, Gattinara GC, Guarino A, Badolato R, Giaquinto C, Lisi C, de Martino M; Italian Register for HIV Infection in Children.

AIDS. 2006 Jan 9;20(2):207-15. Erratum in: AIDS. 2006 Aug 22;20(13):1789. Baddato, Raffaele [corrected to Badolato, Raffaele].

PMID:
16511413
2.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
3.

Primary HIV infection in infants: impact of highly active antiretroviral therapy on the natural course.

De Rossi A.

J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):53-7. Review.

PMID:
12003175
4.

Early versus deferred antiretroviral therapy in children in low-income and middle-income countries.

Puthanakit T, Bunupuradah T.

Curr Opin HIV AIDS. 2010 Jan;5(1):12-7. doi: 10.1097/COH.0b013e3283339b27. Review.

PMID:
20046143
5.

[Recommendations of the CEVIHP/SEIP/AEP/PNS on antiretroviral treatment in HIV-infected children and teenagers].

Ramos JT, de José MI, Polo R, Fortuny C, Mellado MJ, Muñoz-Fernández MA, Beceiro J, Bertrán JM, Calvo C, Chamorro L, Ciria L, Guillén S, González-Montero R, González-Tomé MI, Gurbindo MD, Martín-Fontelos P, Martínez-Pérez J, Moreno D, Muñoz-Almagro MC, Mur A, Navarro ML, Otero C, Rojo P, Rubio B, Saavedra J; Grupo Colaborativo Español de VIH Pediátrico (CEVIHP); Sociedad Española de Infectologia Pediátrica (SEIP); Asociacion Española de Pediatría (AEP); Plan Nacional sobre el SIDA del Ministerio de Sanidad y Consumo.

Enferm Infecc Microbiol Clin. 2005 May;23(5):279-312. Review. Spanish.

PMID:
15899180
6.

Structured treatment interruptions in HIV/AIDS therapy.

Lisziewicz J, Lori F.

Microbes Infect. 2002 Feb;4(2):207-14. Review.

PMID:
11880054
7.

Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance.

Grant PM, Zolopa AR.

Curr Opin Investig Drugs. 2010 Aug;11(8):901-10. Review.

PMID:
20721832
8.

Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.

Abbas UL, Mellors JW.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13377-8. Epub 2002 Oct 7. Review. No abstract available.

9.

[Antiretroviral therapy in children].

Jakob-Sölder B.

Wien Med Wochenschr. 1998;148(23-24):539-46. Review. German.

PMID:
10189683
10.

Optimization of antiretroviral therapy in HIV-infected children under 3 years of age: a systematic review.

Penazzato M, Prendergast AJ, Muhe LM, Tindyebwa D, Abrams EJ.

AIDS. 2014 Mar;28 Suppl 2:S137-46. doi: 10.1097/QAD.0000000000000240. Review.

PMID:
24849473
11.

[When to initiate antiretroviral therapy in HIV-infected children?].

Thuret I.

Arch Pediatr. 2004 Dec;11(12):1521-4. Review. French.

PMID:
15596349
12.

Clinical and biological disease progression in vertically acquired paediatric HIV infection.

Gray L.

Med Wieku Rozwoj. 2003 Oct-Dec;7(4 Pt 1):437-48. Review.

PMID:
15010554
13.

'Test-and-treat': the end of the HIV epidemic?

Cambiano V, Rodger AJ, Phillips AN.

Curr Opin Infect Dis. 2011 Feb;24(1):19-26. doi: 10.1097/QCO.0b013e3283422c8c. Review.

PMID:
21157329
14.

Virologic testing in the management of perinatal HIV exposure.

Cervia J, Kaplan B, Schuval S, Weiss S.

AIDS Read. 2003 Jan;13(1):39-47. Review.

PMID:
12569894
15.

Impact of earlier combination antiretroviral therapy on outcomes in children.

Cotton MF, Rabie H.

Curr Opin HIV AIDS. 2015 Jan;10(1):12-7. doi: 10.1097/COH.0000000000000117. Review.

16.

HIV: new drugs, new guidelines.

Geretti AM, Tsakiroglou M.

Curr Opin Infect Dis. 2014 Dec;27(6):545-53. doi: 10.1097/QCO.0000000000000106. Review.

PMID:
25304395
17.

Strategies of HIV management--when to start.

Youle M.

AIDS. 2002;16 Suppl 4:S145-9. Review. No abstract available.

PMID:
12699011
18.

Antiretroviral drugs in pediatrics.

Rongkavilit C, Asmar BI.

Indian J Pediatr. 2001 Jul;68(7):641-7. Review.

PMID:
11519288
19.

Immediate antiretroviral therapy in young HIV-infected children: benefits and risks.

Collins IJ, Judd A, Gibb DM.

Curr Opin HIV AIDS. 2014 Jan;9(1):87-94. doi: 10.1097/COH.0000000000000027. Review.

20.

Impact of host genetics on HIV disease progression and treatment: new conflicts on an ancient battleground.

Nolan D, Gaudieri S, John M, Mallal S.

AIDS. 2004 Jun 18;18(9):1231-40. Review. No abstract available.

PMID:
15362655
Items per page

Supplemental Content

Write to the Help Desk